Your browser doesn't support javascript.
loading
SEOM guideline in ovarian cancer 2014
Gonzalez-Martín, A; Bover, I; Campo, JM del; Redondo, A; Vidal, L.
Affiliation
  • Gonzalez-Martín, A; MD Anderson Cancer Center. Madrid. Spain
  • Bover, I; MD Anderson Cancer Center. Madrid. Spain
  • Campo, JM del; MD Anderson Cancer Center. Madrid. Spain
  • Redondo, A; MD Anderson Cancer Center. Madrid. Spain
  • Vidal, L; MD Anderson Cancer Center. Madrid. Spain
Clin. transl. oncol. (Print) ; 16(12): 1067-1071, dic. 2014.
Article in English | IBECS | ID: ibc-129877
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
Ovarian cancer is the leading cause of death due to gynecological cancer and the 5th cause of death for cancer in women in Europe. Optimal management of patients with ovarian cancer needs the participation of a well-trained multidisciplinary team. In the last few years, we have observed a significant improvement in the knowledge of the molecular biology of the different histotypes of ovarian cancer that will probably change our standard of care in the forthcoming years. In this Guideline, we summarize the most current evidence for the medical management of ovarian cancer (AU)
RESUMEN
No disponible
Subject(s)
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Ovarian Neoplasms / Chemotherapy, Adjuvant / Molecular Biology Type of study: Diagnostic study / Practice guideline Limits: Female / Humans Language: English Journal: Clin. transl. oncol. (Print) Year: 2014 Document type: Article Institution/Affiliation country: MD Anderson Cancer Center/Spain
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Ovarian Neoplasms / Chemotherapy, Adjuvant / Molecular Biology Type of study: Diagnostic study / Practice guideline Limits: Female / Humans Language: English Journal: Clin. transl. oncol. (Print) Year: 2014 Document type: Article Institution/Affiliation country: MD Anderson Cancer Center/Spain